Sep 13, 2018
Array BioPharma Announces Publication of BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) Phase 3 Overall Survival Data in The Lancet Oncology
Aug 14, 2018
Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2018
Aug 10, 2018
Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors
Aug 07, 2018
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2018 on August 14, 2018
Jul 27, 2018
BRAFTOVI(TM) (encorafenib) + MEKTOVI® (binimetinib) Receives Positive CHMP Opinion for Advanced BRAF-mutant Melanoma
Jun 18, 2018
Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer
Jun 04, 2018
Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma
May 30, 2018
Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference
May 16, 2018
Array BioPharma Announces Oral Presentation from the Pivotal Phase 3 COLUMBUS trial of the Combination of Encorafenib and Binimetinib in Patients with BRAF-mutant Melanoma at 2018 ASCO Annual Meeting
May 09, 2018
Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference
Apr 30, 2018
Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2018 On May 9, 2018
Mar 22, 2018
Array BioPharma Announces Publication of Detailed Phase 3 COLUMBUS Trial Data of Encorafenib and Binimetinib in Melanoma Patients in The Lancet Oncology
Mar 05, 2018
Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference
Jan 30, 2018
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2018 On February 6, 2018
Dec 04, 2017
Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020
Nov 30, 2017
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
Nov 22, 2017
Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference
Nov 08, 2017
Array BioPharma To Present At The 2017 Stifel Healthcare Conference
Oct 24, 2017
Array Biopharma To Report Financial Results For The First Quarter Of Fiscal 2018 On October 31, 2017
Sep 19, 2017
Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference